Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

FDA grants marketing clearance for Volcano's Eagle Eye Platinum digital IVUS catheter

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Eagle Eye® Platinum digital IVUS catheter in the United States.

9 Feb 2010

Volcano acquires Xtract Thrombus Aspiration Catheter device from Lumen Biomedical

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has acquired the Xtract™ Thrombus Aspiration Catheter device line from Lumen Biomedical.

9 Feb 2010

FlowCardia commences enrollment in CROSSER CTO Recanalization Catheter study

FlowCardia, Inc., a worldwide leader in the development of endovascular devices for the treatment of chronic total occlusions (CTOs), today announced Dr. John Paul Runyon from The Christ Hospital in Cincinnati, Ohio successfully enrolled the first patient into the CENTRAL (Crosser ENters The Right Arterial Lumen) study.

9 Feb 2010

BD recalls certain lots of BD Q-Syte Luer Access Devices and BD Nexiva Closed IV Catheter Systems

BD (Becton, Dickinson and Company) has voluntarily executed a product recall of certain lots of BD Q-Syte™ Luer Access Devices and BD Nexiva™ Closed IV Catheter Systems. Use of the affected devices may cause an air embolism or leakage of blood and/or therapy, which may result in serious injury or death. This field corrective action included notification to customers worldwide by letter. Neither the costs anticipated with the recall, nor the impact on BD's business, are expected to be material.

From BD (Becton, Dickinson and Company) 9 Feb 2010

Stereotaxis Magnetic Navigation System installed at CHMC, Taiwan

Stereotaxis today announced the installation of its first Stereotaxis Magnetic Navigation System in Taiwan at Cheng-Hsin General Hospital (CHMC) located in Taipei. CHMC hosted a Grand Opening event on January 26 that received wide coverage throughout the area and, to date, ten procedures have been successfully performed using Stereotaxis at the hospital.

8 Feb 2010

Two U.S. insurers approve coverage of radioembolization for treatment of unresectable liver cancer

MDS Nordion, a global leader in providing products and services for medical imaging and radiotherapeutics, today announced that two of the largest health insurers in the United States have recently approved coverage of radioembolization to treat unresectable liver cancer, which includes the use of MDS Nordion's TheraSphere(R) treatment. The two insurance companies and their affiliates together serve more than one-quarter of Americans and do business in all 50 states.

6 Feb 2010

Safety checklist reduces bloodstream infections in ICUs

The state of Michigan, which used a five-step checklist developed at Johns Hopkins to virtually eliminate bloodstream infections in its hospitals' intensive care units , has been able to keep the number of these common, costly and potentially lethal infections near zero - even three years after first adopting the standardized procedures.

5 Feb 2010

Bioheart initiates REGEN Phase I Clinical Trial for testing genetically modified MyoCell in CHF patients

Bioheart, Inc., announced today that the company has commenced work on its REGEN trial, a Phase I Clinical Trial to test genetically modified MyoCell® in patients suffering from Congestive Heart Failure (CHF). Bioheart’s MyoCell® is a regenerative cell therapy that uses myoblasts, or muscle stem cells,that are grown from a patient’s own muscle. MyoCell® has been tested successfully on patients in four clinical trials.

5 Feb 2010

State of Michigan keeps lethal hospital infections in check

The state of Michigan, which used a five-step checklist developed at Johns Hopkins to virtually eliminate bloodstream infections in its hospitals' intensive care units , has been able to keep the number of these common, costly and potentially lethal infections near zero — even three years after first adopting the standardized procedures. A report on the work is being published in the February 20 issue of BMJ (British Medical Journal).

4 Feb 2010

New technique may reduce recovery time in arrhythmia patients

A surgeon and an electrophysiologist in the Methodist DeBakey Heart & Vascular Center last week worked together to perform a novel, minimally-invasive procedure to treat a common but dangerous arrhythmia in a 61-year-old lawyer from east Texas who has suffered from the condition for months.

4 Feb 2010

St. Jude Medical to commence enrollment in IRASE AF trial

St. Jude Medical, Inc. today announced it has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin enrollment in the IRASE AF (IRrigated Ablation System Evaluation for AF) trial, a multicenter, randomized, single-blind study evaluating the safety and efficacy of the company’s Duo 12 port open irrigated catheter ablation system for treatment of Atrial Fibrillation (AF). AF is the most common cardiac arrhythmia (abnormal heartbeat), affecting an estimated 3.3 million Americans and millions more worldwide.

4 Feb 2010

Infection rates for 25 Dallas/Fort Worth area hospitals: Consumer Reports

Hospitals in the Dallas/Fort Worth area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 25 Dallas/Fort Worth area hospitals along with other critical patient safety and satisfaction information for consumers.

2 Feb 2010

Consumer Reports to post hospital infection rates for 10 Tampa/St. Petersburg area hospitals

Hospitals in the Tampa/St. Petersburg area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable.

2 Feb 2010

Atlanta Hamilton Medical Center reports zero central line infection

Hospitals in the Atlanta area vary in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 12 Atlanta area hospitals that voluntarily reported their infection rates.

2 Feb 2010

Central-line bloodstream infections rate vary in San Francisco hospitals

Hospitals in San Francisco vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable.

2 Feb 2010

No Chicago hospital reports zero central line infections

Hospitals in the Chicago area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 15 Chicago hospitals along with other critical patient safety and satisfaction information for consumers.

2 Feb 2010

Infection rates in Boston hospitals vary substantially, says Consumer Reports Health

Hospitals in the Boston area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable.

2 Feb 2010

Hospitals in Houston area vary in terms of how well their ICUs prevent bloodstream infections

Hospitals in the Houston area vary in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable.

2 Feb 2010

Four Detroit area hospitals announce worse than average infection rates

Hospitals in the Detroit area vary dramatically in terms of how well their intensive care units (ICUs) prevent central-line bloodstream infections, a cause of death, disability, and expense in our nations' hospitals that is largely preventable. On February 2, www.ConsumerReportsHealth.org will post hospital infection rates for 25 Detroit area hospitals, along with other critical patient safety and satisfaction information for consumers.

2 Feb 2010

New online ratings provide patients with easy access to hospital infection rates

Far too many hospitals expose patients to deadly central-line bloodstream infections despite the availability of a simple life-saving checklist proven to prevent hospital acquired infections, says a new investigative article in the March issue of Consumer Reports.

2 Feb 2010

Catheter News and Research

Further Reading

FDA grants marketing clearance for Volcano's Eagle Eye Platinum digital IVUS catheter

Volcano acquires Xtract Thrombus Aspiration Catheter device from Lumen Biomedical

FlowCardia commences enrollment in CROSSER CTO Recanalization Catheter study

BD recalls certain lots of BD Q-Syte Luer Access Devices and BD Nexiva Closed IV Catheter Systems

Stereotaxis Magnetic Navigation System installed at CHMC, Taiwan

Two U.S. insurers approve coverage of radioembolization for treatment of unresectable liver cancer

Safety checklist reduces bloodstream infections in ICUs

Bioheart initiates REGEN Phase I Clinical Trial for testing genetically modified MyoCell in CHF patients

State of Michigan keeps lethal hospital infections in check

New technique may reduce recovery time in arrhythmia patients

St. Jude Medical to commence enrollment in IRASE AF trial

Infection rates for 25 Dallas/Fort Worth area hospitals: Consumer Reports

Consumer Reports to post hospital infection rates for 10 Tampa/St. Petersburg area hospitals

Atlanta Hamilton Medical Center reports zero central line infection

Central-line bloodstream infections rate vary in San Francisco hospitals

No Chicago hospital reports zero central line infections

Infection rates in Boston hospitals vary substantially, says Consumer Reports Health

Hospitals in Houston area vary in terms of how well their ICUs prevent bloodstream infections

Four Detroit area hospitals announce worse than average infection rates

New online ratings provide patients with easy access to hospital infection rates

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News